-
We just opened our newest ambulatory surgery center (ASC) in Texas this week. We think it is our 206th, but we could be off on that number. While it is an ASC, there is some useful information for our hospital readers here. Please read on!
-
In 2010, the number of unintended retentions of a foreign body jumped to the highest level since The Joint Commission started tracking statistics in 1995: 133 reported events. Already, through the third quarter of 2011, there have been 136 incidents reported to the agency.
-
It could happen, says Eric Chiu, founder & president of HyTrust, a company in Mountain View, CA, that specializes in access control for data. It likely would be caused by someone employed or formerly employed at your organization, he says.
-
In the first weeks of the 2009 H1N1 pandemic, a physician became ill at a Chicago hospital and tested positive for the virus. Then other healthcare workers became ill and tested positive an outbreak that began at a time when the virus was not widespread in the community.
-
In an era when controversial mandatory flu vaccine policies threaten to end up in some high court as a cause célèbre, The Joint Commission is urging healthcare organizations to go for the proverbial gold.
-
In the waning days of the comment period for the advance notice of proposed rule-making (ANPRM) for human subjects protection regulation, some of the IRB community's heavy hitters have weighed in.
-
When investigators seek an exception from informed consent (EFIC) for emergency research, they must show that they have engaged in community consultation and public disclosure, informing the public that they may encounter an experimental intervention while being treated in an emergency setting.
-
In the proposed revision of the Common Rule, the Department of Health and Human Services (HHS) responds to years of complaints about informed consent documents that they're too long, too complicated, too full of boilerplate and risk management language.
-
Research ethicists and others have long described the value of recruiting more minorities in clinical research (CR) trials, but the question is whether or not IRBs have a role to play in advancing this goal.
-
In assessing the recent revisions to the Common Rule proposed by the Department of Health and Human Services (HHS), the accrediting agency for human subjects protection programs suggests that HHS may lack the necessary information to move forward with a final rule.